Shots:

• Nevakar received US FDA’s approval to market Ephedrine Sulfate Injection (50mg/10 ml) in a ready to use vial presentation and it is the 1^st approval under collaboration b\w Nevakar and Endo for the development of sterile injectable product in the US and Canada
• Nevakar to develop and obtain FDA approval for these products and Par Pharmaceuticals Sterile Products division will launch and distribute the products
• The company is focused on developing and commercializing innovative products to address unmet medical needs- thereby improving patient care and quality of life

­ Ref: PRNewswire | Image: Nevakar